Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
Public ClinicalTrials.gov record NCT02919982. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation: A Study of Clinical Characteristics With Insight From Patient and Physician Perspectives
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to establish a benchmark for rate of prescription of oral anticoagulants (OA) in patients with non-valvular atrial fibrillation (NVAF) seen in an ambulatory care setting, based on independent medical assessment of clinical data and physician and patient surveys. The study will also assess reasons for not prescribing OA to prevent thromboembolic complications in patients with NVAF seen in ambulatory care, and patients' perspectives of non-use of OA for treatment of NVAF.
Study identification
- NCT ID
- NCT02919982
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 817 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2016
- Primary completion
- Apr 30, 2018
- Completion
- Aug 31, 2019
- Last update posted
- Jul 26, 2022
2017 – 2019
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Heart Institute | Anchorage | Alaska | 95508 | — |
| Orange County Heart Institute and Research Center | Orange | California | 92868 | — |
| Clearwater Cardiovascular & Interventional Consultants MD PA | Clearwater | Florida | 33756 | — |
| Holy Cross Hospital, Inc. | Fort Lauderdale | Florida | 33308 | — |
| Heartwell LLP | Miami | Florida | 33173 | — |
| Cardiac Institute of the Palm Beaches | Palm Beach Gardens | Florida | 33410 | — |
| Adventist Health Partners, Inc. Amita Health | Hinsdale | Illinois | 60521 | — |
| Delmarva Heart LLC | Salisbury | Maryland | 21804 | — |
| Michigan Heart - St. Joseph Mercy Health System | Ann Arbor | Michigan | 48197 | — |
| Munson Medical Group | Traverse City | Michigan | 49684 | — |
| CardioCare, PC | Hillsborough | New Jersey | 08844 | — |
| ProMedica Toledo Hospital | Toledo | Ohio | 43606 | — |
| Southern Oregon Cardiology | Medford | Oregon | 97504 | — |
| Cardiology Consultants of Philadelphia - Lansdale | Lansdale | Pennsylvania | 19446 | — |
| The Heart Institute of East Texas | Lufkin | Texas | 75904 | — |
| Waco Cardiology Associates | Waco | Texas | 20037 | — |
| Revere Health-Heart of Dixie Cardiology Central Utah Clinic PC | St. George | Utah | 84790 | — |
| Centra Health, Inc. dba Stroobants Cardiovascular Center | Lynchburg | Virginia | 24501 | — |
| Virginia Cardiovascular Specialists | Richmond | Virginia | 23229 | — |
| Western Washington Medical Group, Inc. | Everett | Washington | 98208 | — |
| Kootenai Health dba Heart Clinics of the Northwest | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02919982, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02919982 live on ClinicalTrials.gov.